Patients The forgotten few: Why the kidney transplant system is faili... While innovation has reshaped therapeutic areas like oncology, transplant medicine has, by comparison, stood still.
Digital Maternity care needs improvement, healthtech can help The Birth Trauma Inquiry collected evidence from 1,300 women and found that maternity care of “
Patients Navigating transplant networks: Ensuring equitable access an... Over three million people live with kidney disease in the UK. Some will progress to end-stage kidney disease, which is ultimately fatal, without either dialysis or kidney transplant.
News Ipsen charts $1.75bn course for Kartos acquisition Ipsen has agreed to buy cancer biotech Kartos Therapeutics for $450m upfront, adding a late-stage drug in the challenging MDM2 inhibitor class.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.